Xiao Longkai, Liu Aiguo, Ma Hualiang, Jiang Hongqun
Department of Otolaryngology Head and Neck Surgery,the First Affiliated Hospital of Nanchang University,Nanchang,330006,China.
Department of Otolaryngology Head and Neck Surgery,Tongji Hospital,Huazhong University of Science and Technology.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Jul;36(7):559-565. doi: 10.13201/j.issn.2096-7993.2022.07.017.
Temporal bone squamous cell carcinoma, which is rare in the clinical setting, is the most common type of temporal bone malignancy. Its rarity makes the staging, the way of temporal bone resection, the management of parotid gland and cervical lymph node, and the application of radiotherapy and chemotherapy still controversial.There is no unanimous consensus and guideline about it to date at home and abroad.This paper reviewed the recent advance in the diagnosis and treatment of temporal bone squamous cell carcinoma in the hope of providing some help and reference for the management of the disease.
颞骨鳞状细胞癌在临床中较为罕见,是颞骨恶性肿瘤最常见的类型。其罕见性使得分期、颞骨切除方式、腮腺及颈部淋巴结的处理以及放疗和化疗的应用仍存在争议。迄今为止,国内外对此尚无一致的共识和指南。本文综述了颞骨鳞状细胞癌诊断和治疗的最新进展,以期为该疾病的管理提供一些帮助和参考。